• Home
  • Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.

Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events.

Author List
Middha P, Thummalapalli R, Quandt Z, Balaratnam K, Cardenas E, Falcon CJ, Princess Margaret Lung Group, Gubens MA, Huntsman S, Khan K, Li M, Lovly CM, Patel D, Zhan LJ, Liu G, Aldrich MC, Schoenfeld AJ, Ziv E
Publication
medRxiv : the preprint server for health sciences
Publication ID (Profile URL)
https://researcherprofiles.org/profile/524431351
Publication Year
2024
PubMed ID
38947092
Publication Title
Middha P, Thummalapalli R, Quandt Z, Balaratnam K, Cardenas E, Falcon CJ, Princess Margaret Lung Group, Gubens MA, Huntsman S, Khan K, Li M, Lovly CM, Patel D, Zhan LJ, Liu G, Aldrich MC, Schoenfeld AJ, Ziv E. Germline prediction of immune checkpoint inhibitor discontinuation for immune-related adverse events. medRxiv. 2024 Jun 11.